Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ascites, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07435701
What this trial is testing

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Who this might be right for
Ovarian Neoplasms MalignantAscites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Testing effectiveness (Phase 2)Study completedNCT00396591
What this trial is testing

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian Neoplasms
Sanofi 16
Not applicableEnded earlyNCT01077063
What this trial is testing

An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites

Who this might be right for
Malignant Ascites
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 7
Not applicableStudy completedNCT07023042
What this trial is testing

Kinesio-Taping vs. Usual Care for Malignant Bowel Obstruction With Ascites

Who this might be right for
Malignant Bowel ObstructionAscitesAdvanced Cancer
National Taiwan University Hospital 38
Not applicableNot Yet RecruitingNCT06496919
What this trial is testing

A Real-world Research on the Prevention and Treatment of Peritoneal Metastasis and Malignant Ascites by Intraperitoneal Infusion of rmhTNF in Gastric and Colorectal Malignant Tumors

Who this might be right for
Gastric Cancer
Wuhan University 300
Testing effectiveness (Phase 2)Study completedNCT02638051
What this trial is testing

Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT

Who this might be right for
Peritoneal NeoplasmsAscitesYang Deficiency+1 more
Galenic Research Institute Ltd 260
Not applicableEnrolling By InvitationNCT05745233
What this trial is testing

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Who this might be right for
Malignant Ascites
China Medical University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT03990103
What this trial is testing

S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

Who this might be right for
Metastatic Gastric Adenocarcinoma
China Medical University, China 66
Large-scale testing (Phase 3)Study completedNCT00836654
What this trial is testing

Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group

Who this might be right for
EpCam Positive Tumor (e.g.Ovarian, Gastric, Colon, Breast)Malignant Ascites
Neovii Biotech 258
Testing effectiveness (Phase 2)WithdrawnNCT00005645
What this trial is testing

ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Fallopian Tube CancerMetastatic CancerOvarian Cancer+1 more
Genzyme, a Sanofi Company
Not applicableStudy completedNCT04032600
What this trial is testing

Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics

Who this might be right for
Malignant AscitesOvarian CancerHemodynamic Instability
Charite University, Berlin, Germany 61
Testing effectiveness (Phase 2)Looking for participantsNCT06759064
What this trial is testing

Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites

Who this might be right for
Cancer of Stomach, AdenocarcinomaAscites, Malignant
Qilu Hospital of Shandong University 24
Testing effectiveness (Phase 2)Study completedNCT01327235
What this trial is testing

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Who this might be right for
Malignant Pleural EffusionMalignant Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd. 336
Early research (Phase 1)Looking for participantsNCT06016179
What this trial is testing

Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer

Who this might be right for
Malignant Pleural EffusionMalignant Ascites
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 12
Early research (Phase 1)WithdrawnNCT03682744
What this trial is testing

CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+4 more
Sorrento Therapeutics, Inc.
Large-scale testing (Phase 3)UnknownNCT03475615
What this trial is testing

Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerStomach Neoplasms
Fudan University 215
Testing effectiveness (Phase 2)Looking for participantsNCT07149090
What this trial is testing

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

Who this might be right for
STOMACH NEOPLASMGastric CancerGastric Cancer Adenocarcinoma Metastatic
Asan Medical Center 61
Testing effectiveness (Phase 2)Looking for participantsNCT06433869
What this trial is testing

The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant Ascites

Who this might be right for
Malignant Ascites
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT00326885
What this trial is testing

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

Who this might be right for
Malignant Ascites
Neovii Biotech 32
Testing effectiveness (Phase 2)Ended earlyNCT02417753
What this trial is testing

AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites

Who this might be right for
Ovarian CancerOvarian NeoplasmsAscites+2 more
National Cancer Institute (NCI) 1
Next Page